A Feasibility Study of the Alliance for Representative Clinical Trials (ARC): Building Clinical Research Capacity in Community-Based Settings
Health Equity · 2026-01 · 10
DOI: 10.1177/24731242261455193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Equity, online erschienen am 02.06.2026. Verfasst von Salvatore Alesci und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Minority Quality Forum, Washington, District of Columbia, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FDA HHS, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Introduction
Most patients receive care in community settings. However, few community clinicians serve as clinical trial investigators. This limits how many underrepresented patients can take part. The National Minority Quality Forum (NMQF) created the Alliance for Representative Clinical Trials (ARC) to support community clinicians in building research capacity while delivering patient care.
Methods
NMQF conducted an early-stage feasibility study to understand the conditions required for equitable patient participation in clinical research. This study examined three areas: recruiting community clinicians, completing foundational research training, and assessing site readiness to offer trials. It also explored the social and structural factors that affect readiness and capacity for equitable research participation.
Results
Ten community clinicians participated in the study, completing training (100%) and site assessments (90%). Eight out of ten (80%) were satisfied with the program and would recommend it. Six out of ten (60%) felt ready to lead a trial. Key barriers included limited staff, infrastructure, and time. Facilitators included trusted recruitment networks and flexible self-paced training.
Discussion
The ARC showed promise in involving community clinicians in clinical research. These findings highlight the need for broader adoption, including mentorship, infrastructure investment, and financial incentives. They also inform future implementation pathways and align with national efforts to make clinical research more accessible and equitable in community care settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Minority Quality Forum, Washington, District of Columbia, USA.
- Patient3i LLC, Branford, Connecticut, USA.
- Tigerlily Foundation, Washington, District of Columbia, USA.
- Dominican University, River Forest, Illinois, USA.
- Community Strengths LLC, Chattahoochee Hills, Georgia, USA.
- Department of Population Health Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
ORCID-Profile: Kristin Bodiford
Förderung
- FDA HHS
- U.S. Food and Drug Administration
Zitieren
APA
Alesci, S., Regnante, J. M., Bodiford, K., Horsford, S. M. E., Coudray, M. S., Battaglia, T. A., Di Dia, N. J., Moore, A. D., Moore, T. S., Edwards, C., & Puckrein, G. (2026). A Feasibility Study of the Alliance for Representative Clinical Trials (ARC): Building Clinical Research Capacity in Community-Based Settings. Health Equity, 10. https://doi.org/10.1177/24731242261455193
Vancouver
Alesci S, Regnante JM, Bodiford K, Horsford SME, Coudray MS, Battaglia TA, et al. A Feasibility Study of the Alliance for Representative Clinical Trials (ARC): Building Clinical Research Capacity in Community-Based Settings. Health Equity. 2026;10. doi:10.1177/24731242261455193
BibTeX
@article{Alesci2026,
author = {Alesci, Salvatore and Regnante, Jeanne M and Bodiford, Kristin and Horsford, Shantia M E and Coudray, Makella S and Battaglia, Tracy A and Di Dia, Nancy J and Moore, Angelo D and Moore, Terri Smith and Edwards, Christina and Puckrein, Gary},
title = {A Feasibility Study of the Alliance for Representative Clinical Trials (ARC): Building Clinical Research Capacity in Community-Based Settings},
journal = {Health Equity},
year = {2026},
volume = {10},
doi = {10.1177/24731242261455193}
}
EUVIMED